Parexel posts huge bookings & begins another hiring spree
Gross bookings at Parexel topped $1bn in the third quarter but the need to accelerate hiring again led to a cut to earnings guidance.
Gross bookings at Parexel topped $1bn in the third quarter but the need to accelerate hiring again led to a cut to earnings guidance.
The Indian government is to invest more than $37m to bring vaccine manufacturing plants in line with cGMPs.
Chiltern has set up a legal entity in Taiwan that will allow it to establish its own local clinical research operations for the first time.
Contract manufacturing organisations (CMOs) have been busy in the past week, with OsoBio expanding its plant and AMRI adopting a new relationship strategy.